nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C8—Nilutamide—prostate cancer	0.1	0.139	CbGbCtD
Pyrimethamine—CYP2C8—Abiraterone—prostate cancer	0.083	0.115	CbGbCtD
Pyrimethamine—CYP2C9—Nilutamide—prostate cancer	0.0698	0.0972	CbGbCtD
Pyrimethamine—CYP2C9—Bicalutamide—prostate cancer	0.0698	0.0972	CbGbCtD
Pyrimethamine—CYP2D6—Bicalutamide—prostate cancer	0.0639	0.0888	CbGbCtD
Pyrimethamine—CYP2C8—Cabazitaxel—prostate cancer	0.0614	0.0854	CbGbCtD
Pyrimethamine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0535	0.0744	CbGbCtD
Pyrimethamine—CYP2D6—Abiraterone—prostate cancer	0.0529	0.0736	CbGbCtD
Pyrimethamine—CYP2C9—Estrone—prostate cancer	0.0418	0.0582	CbGbCtD
Pyrimethamine—CYP2C8—Estradiol—prostate cancer	0.0344	0.0479	CbGbCtD
Pyrimethamine—CYP2C9—Capecitabine—prostate cancer	0.0317	0.0441	CbGbCtD
Pyrimethamine—CYP2C9—Estradiol—prostate cancer	0.024	0.0334	CbGbCtD
Pyrimethamine—CYP2C8—Etoposide—prostate cancer	0.0225	0.0313	CbGbCtD
Pyrimethamine—CYP2D6—Doxorubicin—prostate cancer	0.00978	0.0136	CbGbCtD
Pyrimethamine—CYP2C9—urine—prostate cancer	0.00341	0.163	CbGeAlD
Pyrimethamine—DHFR—prostate gland—prostate cancer	0.00278	0.132	CbGeAlD
Pyrimethamine—CYP2D6—urine—prostate cancer	0.00256	0.122	CbGeAlD
Pyrimethamine—Pancytopenia—Estramustine—prostate cancer	0.00235	0.0262	CcSEcCtD
Pyrimethamine—DHFR—seminal vesicle—prostate cancer	0.00235	0.112	CbGeAlD
Pyrimethamine—Toxic epidermal necrolysis—Flutamide—prostate cancer	0.00228	0.0254	CcSEcCtD
Pyrimethamine—Haematuria—Abiraterone—prostate cancer	0.00205	0.0228	CcSEcCtD
Pyrimethamine—DHFR—renal system—prostate cancer	0.00189	0.0903	CbGeAlD
Pyrimethamine—Haematuria—Nilutamide—prostate cancer	0.00187	0.0208	CcSEcCtD
Pyrimethamine—DHFR—urethra—prostate cancer	0.00186	0.0887	CbGeAlD
Pyrimethamine—Haematuria—Flutamide—prostate cancer	0.00186	0.0207	CcSEcCtD
Pyrimethamine—Erythema multiforme—Estrone—prostate cancer	0.00179	0.0199	CcSEcCtD
Pyrimethamine—Haematuria—Cabazitaxel—prostate cancer	0.00157	0.0175	CcSEcCtD
Pyrimethamine—Erythema multiforme—Estradiol valerate/Dienogest—prostate cancer	0.00156	0.0174	CcSEcCtD
Pyrimethamine—Leukopenia—Estramustine—prostate cancer	0.00154	0.0172	CcSEcCtD
Pyrimethamine—DHFR—bone marrow—prostate cancer	0.00143	0.0682	CbGeAlD
Pyrimethamine—Thrombocytopenia—Estramustine—prostate cancer	0.00138	0.0154	CcSEcCtD
Pyrimethamine—Leukopenia—Nilutamide—prostate cancer	0.00137	0.0153	CcSEcCtD
Pyrimethamine—Leukopenia—Flutamide—prostate cancer	0.00136	0.0152	CcSEcCtD
Pyrimethamine—Haematuria—Bicalutamide—prostate cancer	0.00135	0.015	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Estrone—prostate cancer	0.00135	0.015	CcSEcCtD
Pyrimethamine—Anorexia—Estramustine—prostate cancer	0.00134	0.015	CcSEcCtD
Pyrimethamine—Decreased appetite—Estramustine—prostate cancer	0.00122	0.0136	CcSEcCtD
Pyrimethamine—DHFR—testis—prostate cancer	0.00122	0.0583	CbGeAlD
Pyrimethamine—Thrombocytopenia—Flutamide—prostate cancer	0.00122	0.0136	CcSEcCtD
Pyrimethamine—Anorexia—Nilutamide—prostate cancer	0.00119	0.0133	CcSEcCtD
Pyrimethamine—Anorexia—Flutamide—prostate cancer	0.00119	0.0132	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.00117	0.0131	CcSEcCtD
Pyrimethamine—Leukopenia—Cabazitaxel—prostate cancer	0.00115	0.0128	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Degarelix—prostate cancer	0.00112	0.0124	CcSEcCtD
Pyrimethamine—Decreased appetite—Nilutamide—prostate cancer	0.00109	0.0121	CcSEcCtD
Pyrimethamine—Decreased appetite—Flutamide—prostate cancer	0.00108	0.012	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Cabazitaxel—prostate cancer	0.00103	0.0115	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ethinyl Estradiol—prostate cancer	0.00101	0.0113	CcSEcCtD
Pyrimethamine—Anorexia—Cabazitaxel—prostate cancer	0.001	0.0112	CcSEcCtD
Pyrimethamine—Decreased appetite—Degarelix—prostate cancer	0.00097	0.0108	CcSEcCtD
Pyrimethamine—CYP2C8—renal system—prostate cancer	0.00094	0.0448	CbGeAlD
Pyrimethamine—Haematuria—Goserelin—prostate cancer	0.000938	0.0105	CcSEcCtD
Pyrimethamine—Decreased appetite—Cabazitaxel—prostate cancer	0.000914	0.0102	CcSEcCtD
Pyrimethamine—Vomiting—Estramustine—prostate cancer	0.000896	0.00998	CcSEcCtD
Pyrimethamine—DHFR—lymph node—prostate cancer	0.000887	0.0423	CbGeAlD
Pyrimethamine—Thrombocytopenia—Bicalutamide—prostate cancer	0.000883	0.00984	CcSEcCtD
Pyrimethamine—Vomiting—Abiraterone—prostate cancer	0.00087	0.00969	CcSEcCtD
Pyrimethamine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000865	0.00964	CcSEcCtD
Pyrimethamine—Anorexia—Bicalutamide—prostate cancer	0.00086	0.00958	CcSEcCtD
Pyrimethamine—Vomiting—Estrone—prostate cancer	0.000855	0.00953	CcSEcCtD
Pyrimethamine—Erythema multiforme—Conjugated Estrogens—prostate cancer	0.000827	0.00922	CcSEcCtD
Pyrimethamine—Hypersensitivity—Degarelix—prostate cancer	0.000823	0.00916	CcSEcCtD
Pyrimethamine—Vomiting—Nilutamide—prostate cancer	0.000795	0.00885	CcSEcCtD
Pyrimethamine—Vomiting—Flutamide—prostate cancer	0.000791	0.00881	CcSEcCtD
Pyrimethamine—Decreased appetite—Bicalutamide—prostate cancer	0.000784	0.00874	CcSEcCtD
Pyrimethamine—Hypersensitivity—Cabazitaxel—prostate cancer	0.000775	0.00863	CcSEcCtD
Pyrimethamine—Pancytopenia—Mitoxantrone—prostate cancer	0.000774	0.00862	CcSEcCtD
Pyrimethamine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000747	0.00832	CcSEcCtD
Pyrimethamine—Haematuria—Estradiol—prostate cancer	0.000744	0.00829	CcSEcCtD
Pyrimethamine—Vomiting—Degarelix—prostate cancer	0.00071	0.00791	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Etoposide—prostate cancer	0.000706	0.00787	CcSEcCtD
Pyrimethamine—Haematuria—Mitoxantrone—prostate cancer	0.000693	0.00772	CcSEcCtD
Pyrimethamine—Leukopenia—Goserelin—prostate cancer	0.000688	0.00767	CcSEcCtD
Pyrimethamine—Vomiting—Cabazitaxel—prostate cancer	0.000669	0.00745	CcSEcCtD
Pyrimethamine—Hypersensitivity—Bicalutamide—prostate cancer	0.000665	0.0074	CcSEcCtD
Pyrimethamine—Erythema multiforme—Estradiol—prostate cancer	0.000662	0.00738	CcSEcCtD
Pyrimethamine—Pancytopenia—Etoposide—prostate cancer	0.000644	0.00717	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Goserelin—prostate cancer	0.000628	0.00699	CcSEcCtD
Pyrimethamine—CYP2D6—renal system—prostate cancer	0.000627	0.0299	CbGeAlD
Pyrimethamine—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000622	0.00692	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Goserelin—prostate cancer	0.000614	0.00684	CcSEcCtD
Pyrimethamine—CYP2C8—testis—prostate cancer	0.000608	0.029	CbGeAlD
Pyrimethamine—Stevens-Johnson syndrome—Etoposide—prostate cancer	0.000599	0.00668	CcSEcCtD
Pyrimethamine—Anorexia—Goserelin—prostate cancer	0.000598	0.00666	CcSEcCtD
Pyrimethamine—Anorexia—Conjugated Estrogens—prostate cancer	0.000593	0.0066	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Docetaxel—prostate cancer	0.000587	0.00654	CcSEcCtD
Pyrimethamine—Vomiting—Bicalutamide—prostate cancer	0.000574	0.00639	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Capecitabine—prostate cancer	0.000568	0.00633	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000562	0.00626	CcSEcCtD
Pyrimethamine—Decreased appetite—Goserelin—prostate cancer	0.000546	0.00608	CcSEcCtD
Pyrimethamine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.00054	0.00602	CcSEcCtD
Pyrimethamine—Pancytopenia—Docetaxel—prostate cancer	0.000535	0.00596	CcSEcCtD
Pyrimethamine—Pancytopenia—Capecitabine—prostate cancer	0.000518	0.00577	CcSEcCtD
Pyrimethamine—Erythema multiforme—Etoposide—prostate cancer	0.000513	0.00572	CcSEcCtD
Pyrimethamine—Leukopenia—Mitoxantrone—prostate cancer	0.000508	0.00566	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000498	0.00555	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Estradiol—prostate cancer	0.000498	0.00554	CcSEcCtD
Pyrimethamine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000485	0.0054	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000482	0.00537	CcSEcCtD
Pyrimethamine—Haematuria—Capecitabine—prostate cancer	0.000464	0.00517	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000464	0.00516	CcSEcCtD
Pyrimethamine—Hypersensitivity—Goserelin—prostate cancer	0.000462	0.00515	CcSEcCtD
Pyrimethamine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000458	0.0051	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000454	0.00506	CcSEcCtD
Pyrimethamine—Anorexia—Mitoxantrone—prostate cancer	0.000442	0.00492	CcSEcCtD
Pyrimethamine—Decreased appetite—Estradiol—prostate cancer	0.000433	0.00482	CcSEcCtD
Pyrimethamine—Erythema multiforme—Docetaxel—prostate cancer	0.000426	0.00475	CcSEcCtD
Pyrimethamine—Leukopenia—Etoposide—prostate cancer	0.000423	0.00471	CcSEcCtD
Pyrimethamine—Erythema multiforme—Capecitabine—prostate cancer	0.000413	0.0046	CcSEcCtD
Pyrimethamine—CYP2D6—testis—prostate cancer	0.000405	0.0193	CbGeAlD
Pyrimethamine—Decreased appetite—Mitoxantrone—prostate cancer	0.000403	0.00449	CcSEcCtD
Pyrimethamine—Vomiting—Goserelin—prostate cancer	0.000399	0.00444	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000396	0.00441	CcSEcCtD
Pyrimethamine—Vomiting—Conjugated Estrogens—prostate cancer	0.000395	0.0044	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Etoposide—prostate cancer	0.000386	0.0043	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Etoposide—prostate cancer	0.000378	0.00421	CcSEcCtD
Pyrimethamine—Anorexia—Etoposide—prostate cancer	0.000368	0.00409	CcSEcCtD
Pyrimethamine—Hypersensitivity—Estradiol—prostate cancer	0.000367	0.00408	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000366	0.00408	CcSEcCtD
Pyrimethamine—Pancytopenia—Epirubicin—prostate cancer	0.000361	0.00402	CcSEcCtD
Pyrimethamine—Leukopenia—Docetaxel—prostate cancer	0.000351	0.00392	CcSEcCtD
Pyrimethamine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000342	0.0038	CcSEcCtD
Pyrimethamine—Leukopenia—Capecitabine—prostate cancer	0.00034	0.00379	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000336	0.00374	CcSEcCtD
Pyrimethamine—Decreased appetite—Etoposide—prostate cancer	0.000335	0.00373	CcSEcCtD
Pyrimethamine—Pancytopenia—Doxorubicin—prostate cancer	0.000334	0.00372	CcSEcCtD
Pyrimethamine—Haematuria—Epirubicin—prostate cancer	0.000323	0.0036	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Docetaxel—prostate cancer	0.00032	0.00357	CcSEcCtD
Pyrimethamine—Vomiting—Estradiol—prostate cancer	0.000316	0.00352	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Docetaxel—prostate cancer	0.000314	0.0035	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000311	0.00346	CcSEcCtD
Pyrimethamine—Anorexia—Docetaxel—prostate cancer	0.000305	0.0034	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Capecitabine—prostate cancer	0.000304	0.00338	CcSEcCtD
Pyrimethamine—Haematuria—Doxorubicin—prostate cancer	0.000299	0.00333	CcSEcCtD
Pyrimethamine—Anorexia—Capecitabine—prostate cancer	0.000296	0.00329	CcSEcCtD
Pyrimethamine—Vomiting—Mitoxantrone—prostate cancer	0.000295	0.00328	CcSEcCtD
Pyrimethamine—Erythema multiforme—Epirubicin—prostate cancer	0.000288	0.0032	CcSEcCtD
Pyrimethamine—Hypersensitivity—Etoposide—prostate cancer	0.000284	0.00316	CcSEcCtD
Pyrimethamine—Decreased appetite—Docetaxel—prostate cancer	0.000279	0.0031	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Prednisone—prostate cancer	0.000276	0.00308	CcSEcCtD
Pyrimethamine—Decreased appetite—Capecitabine—prostate cancer	0.00027	0.003	CcSEcCtD
Pyrimethamine—Erythema multiforme—Doxorubicin—prostate cancer	0.000266	0.00296	CcSEcCtD
Pyrimethamine—Anorexia—Prednisone—prostate cancer	0.000263	0.00293	CcSEcCtD
Pyrimethamine—Vomiting—Etoposide—prostate cancer	0.000245	0.00273	CcSEcCtD
Pyrimethamine—Decreased appetite—Prednisone—prostate cancer	0.00024	0.00268	CcSEcCtD
Pyrimethamine—Leukopenia—Epirubicin—prostate cancer	0.000237	0.00264	CcSEcCtD
Pyrimethamine—Hypersensitivity—Docetaxel—prostate cancer	0.000236	0.00263	CcSEcCtD
Pyrimethamine—Hypersensitivity—Capecitabine—prostate cancer	0.000229	0.00255	CcSEcCtD
Pyrimethamine—Leukopenia—Doxorubicin—prostate cancer	0.000219	0.00244	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Epirubicin—prostate cancer	0.000216	0.00241	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Epirubicin—prostate cancer	0.000212	0.00236	CcSEcCtD
Pyrimethamine—Anorexia—Epirubicin—prostate cancer	0.000206	0.0023	CcSEcCtD
Pyrimethamine—Vomiting—Docetaxel—prostate cancer	0.000204	0.00227	CcSEcCtD
Pyrimethamine—Hypersensitivity—Prednisone—prostate cancer	0.000204	0.00227	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Doxorubicin—prostate cancer	0.0002	0.00223	CcSEcCtD
Pyrimethamine—Vomiting—Capecitabine—prostate cancer	0.000197	0.0022	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Doxorubicin—prostate cancer	0.000196	0.00218	CcSEcCtD
Pyrimethamine—Anorexia—Doxorubicin—prostate cancer	0.000191	0.00212	CcSEcCtD
Pyrimethamine—Decreased appetite—Epirubicin—prostate cancer	0.000188	0.00209	CcSEcCtD
Pyrimethamine—Vomiting—Prednisone—prostate cancer	0.000176	0.00196	CcSEcCtD
Pyrimethamine—Decreased appetite—Doxorubicin—prostate cancer	0.000174	0.00194	CcSEcCtD
Pyrimethamine—Hypersensitivity—Epirubicin—prostate cancer	0.000159	0.00177	CcSEcCtD
Pyrimethamine—Hypersensitivity—Doxorubicin—prostate cancer	0.000147	0.00164	CcSEcCtD
Pyrimethamine—Vomiting—Epirubicin—prostate cancer	0.000137	0.00153	CcSEcCtD
Pyrimethamine—Vomiting—Doxorubicin—prostate cancer	0.000127	0.00142	CcSEcCtD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.88e-05	0.00011	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—prostate cancer	1.88e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA4—prostate cancer	1.88e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TBXAS1—prostate cancer	1.88e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSD17B3—prostate cancer	1.87e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ACSL4—prostate cancer	1.87e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.85e-05	0.000109	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.83e-05	0.000108	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA2—prostate cancer	1.83e-05	0.000107	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CD—prostate cancer	1.82e-05	0.000107	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ARG2—prostate cancer	1.81e-05	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—UMPS—prostate cancer	1.81e-05	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PHGDH—prostate cancer	1.81e-05	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SULT1A1—prostate cancer	1.81e-05	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG5—prostate cancer	1.81e-05	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ARG2—prostate cancer	1.8e-05	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PHGDH—prostate cancer	1.8e-05	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—UMPS—prostate cancer	1.8e-05	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.79e-05	0.000105	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN1B—prostate cancer	1.78e-05	0.000104	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LDHB—prostate cancer	1.78e-05	0.000104	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA1—prostate cancer	1.76e-05	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LDHB—prostate cancer	1.76e-05	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NAT2—prostate cancer	1.74e-05	0.000102	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTO1—prostate cancer	1.74e-05	0.000102	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HSD3B2—prostate cancer	1.74e-05	0.000102	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP3A5—prostate cancer	1.74e-05	0.000102	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP3A5—prostate cancer	1.73e-05	0.000101	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NOS3—prostate cancer	1.72e-05	0.000101	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PDHA1—prostate cancer	1.68e-05	9.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA3—prostate cancer	1.68e-05	9.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—UCP3—prostate cancer	1.68e-05	9.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TCN2—prostate cancer	1.68e-05	9.88e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CTNNB1—prostate cancer	1.68e-05	9.85e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.68e-05	9.84e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLCB2—prostate cancer	1.67e-05	9.81e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LRP2—prostate cancer	1.67e-05	9.81e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2C18—prostate cancer	1.67e-05	9.81e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PDHA1—prostate cancer	1.67e-05	9.79e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA3—prostate cancer	1.67e-05	9.79e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—UCP3—prostate cancer	1.67e-05	9.79e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TCN2—prostate cancer	1.67e-05	9.79e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN1A—prostate cancer	1.64e-05	9.62e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—P4HB—prostate cancer	1.64e-05	9.62e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTEN—prostate cancer	1.64e-05	9.6e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSD3B1—prostate cancer	1.61e-05	9.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC22A3—prostate cancer	1.61e-05	9.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC22A1—prostate cancer	1.6e-05	9.36e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC22A3—prostate cancer	1.59e-05	9.34e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSD3B1—prostate cancer	1.59e-05	9.34e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CB—prostate cancer	1.59e-05	9.3e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.58e-05	9.25e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—prostate cancer	1.57e-05	9.22e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EP300—prostate cancer	1.56e-05	9.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SULT2A1—prostate cancer	1.56e-05	9.12e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.55e-05	9.06e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TBXAS1—prostate cancer	1.54e-05	9.03e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA4—prostate cancer	1.54e-05	9.03e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MED12—prostate cancer	1.53e-05	8.97e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA4—prostate cancer	1.53e-05	8.95e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TBXAS1—prostate cancer	1.53e-05	8.95e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SRC—prostate cancer	1.52e-05	8.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GNG5—prostate cancer	1.52e-05	8.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA2—prostate cancer	1.5e-05	8.8e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.49e-05	8.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA2—prostate cancer	1.49e-05	8.73e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SULT1A1—prostate cancer	1.48e-05	8.69e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG5—prostate cancer	1.48e-05	8.69e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG5—prostate cancer	1.47e-05	8.62e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SULT1A1—prostate cancer	1.47e-05	8.62e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—STAT3—prostate cancer	1.46e-05	8.58e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA3—prostate cancer	1.46e-05	8.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA1—prostate cancer	1.45e-05	8.49e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.44e-05	8.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA1—prostate cancer	1.44e-05	8.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTO1—prostate cancer	1.43e-05	8.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSD3B2—prostate cancer	1.43e-05	8.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NAT2—prostate cancer	1.43e-05	8.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NAT2—prostate cancer	1.42e-05	8.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSD3B2—prostate cancer	1.42e-05	8.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTO1—prostate cancer	1.42e-05	8.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HPGDS—prostate cancer	1.39e-05	8.18e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2C19—prostate cancer	1.39e-05	8.13e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLCB2—prostate cancer	1.37e-05	8.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LRP2—prostate cancer	1.37e-05	8.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2C18—prostate cancer	1.37e-05	8.05e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTEN—prostate cancer	1.37e-05	8.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.37e-05	8e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LRP2—prostate cancer	1.36e-05	7.98e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLCB2—prostate cancer	1.36e-05	7.98e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2C18—prostate cancer	1.36e-05	7.98e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MYC—prostate cancer	1.36e-05	7.98e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—prostate cancer	1.36e-05	7.96e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ACHE—prostate cancer	1.35e-05	7.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTT1—prostate cancer	1.35e-05	7.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—P4HB—prostate cancer	1.35e-05	7.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2A6—prostate cancer	1.34e-05	7.84e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—P4HB—prostate cancer	1.34e-05	7.83e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.33e-05	7.81e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGFR—prostate cancer	1.33e-05	7.8e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC22A1—prostate cancer	1.31e-05	7.68e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—EP300—prostate cancer	1.31e-05	7.66e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKR1C3—prostate cancer	1.3e-05	7.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC22A1—prostate cancer	1.3e-05	7.61e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PRKACB—prostate cancer	1.29e-05	7.59e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.28e-05	7.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP17A1—prostate cancer	1.28e-05	7.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SULT2A1—prostate cancer	1.28e-05	7.48e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SULT2A1—prostate cancer	1.27e-05	7.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.26e-05	7.4e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KRAS—prostate cancer	1.26e-05	7.37e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MED12—prostate cancer	1.26e-05	7.36e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GNG5—prostate cancer	1.25e-05	7.31e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MED12—prostate cancer	1.25e-05	7.3e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GNG5—prostate cancer	1.24e-05	7.24e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA2—prostate cancer	1.22e-05	7.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA3—prostate cancer	1.2e-05	7.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA3—prostate cancer	1.19e-05	6.98e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.17e-05	6.86e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC5A5—prostate cancer	1.16e-05	6.82e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CA—prostate cancer	1.15e-05	6.77e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HPGDS—prostate cancer	1.15e-05	6.71e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2C19—prostate cancer	1.14e-05	6.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2E1—prostate cancer	1.14e-05	6.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HPGDS—prostate cancer	1.14e-05	6.66e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2C19—prostate cancer	1.13e-05	6.61e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NQO1—prostate cancer	1.12e-05	6.59e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ACHE—prostate cancer	1.11e-05	6.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTT1—prostate cancer	1.11e-05	6.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TH—prostate cancer	1.11e-05	6.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTT1—prostate cancer	1.1e-05	6.46e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ACHE—prostate cancer	1.1e-05	6.46e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.1e-05	6.45e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2A6—prostate cancer	1.1e-05	6.44e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP3A4—prostate cancer	1.1e-05	6.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.09e-05	6.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2A6—prostate cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.08e-05	6.36e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1B1—prostate cancer	1.08e-05	6.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKR1C3—prostate cancer	1.07e-05	6.26e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PRKACB—prostate cancer	1.06e-05	6.23e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.06e-05	6.21e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PRKACB—prostate cancer	1.05e-05	6.17e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.05e-05	6.16e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GGT1—prostate cancer	1.04e-05	6.12e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP17A1—prostate cancer	1.04e-05	6.11e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA1—prostate cancer	1.03e-05	6.03e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.03e-05	6.03e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—prostate cancer	1.02e-05	6e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP19A1—prostate cancer	1.01e-05	5.94e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA2—prostate cancer	1e-05	5.87e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA2—prostate cancer	9.93e-06	5.82e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—RXRA—prostate cancer	9.78e-06	5.73e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CA—prostate cancer	9.67e-06	5.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC5A5—prostate cancer	9.56e-06	5.6e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.51e-06	5.58e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC5A5—prostate cancer	9.47e-06	5.55e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—prostate cancer	9.43e-06	5.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—COMT—prostate cancer	9.42e-06	5.52e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTP1—prostate cancer	9.38e-06	5.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2E1—prostate cancer	9.33e-06	5.47e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2E1—prostate cancer	9.25e-06	5.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NQO1—prostate cancer	9.23e-06	5.41e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ITPR1—prostate cancer	9.23e-06	5.41e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NQO1—prostate cancer	9.15e-06	5.36e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TH—prostate cancer	9.1e-06	5.33e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.07e-06	5.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TH—prostate cancer	9.02e-06	5.29e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP3A4—prostate cancer	9e-06	5.28e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.96e-06	5.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP3A4—prostate cancer	8.92e-06	5.23e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.88e-06	5.2e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1B1—prostate cancer	8.85e-06	5.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1B1—prostate cancer	8.77e-06	5.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TYMS—prostate cancer	8.72e-06	5.11e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—prostate cancer	8.62e-06	5.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GGT1—prostate cancer	8.57e-06	5.02e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GGT1—prostate cancer	8.5e-06	4.98e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LPL—prostate cancer	8.46e-06	4.96e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA1—prostate cancer	8.44e-06	4.95e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA1—prostate cancer	8.37e-06	4.91e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP19A1—prostate cancer	8.32e-06	4.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP19A1—prostate cancer	8.25e-06	4.84e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1A1—prostate cancer	8.17e-06	4.79e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ERCC2—prostate cancer	8.1e-06	4.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—RXRA—prostate cancer	8.03e-06	4.71e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—RXRA—prostate cancer	7.96e-06	4.67e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—prostate cancer	7.9e-06	4.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.74e-06	4.54e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—COMT—prostate cancer	7.74e-06	4.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTP1—prostate cancer	7.7e-06	4.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—COMT—prostate cancer	7.67e-06	4.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTP1—prostate cancer	7.63e-06	4.47e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTHFR—prostate cancer	7.62e-06	4.46e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ITPR1—prostate cancer	7.58e-06	4.44e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ITPR1—prostate cancer	7.51e-06	4.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARA—prostate cancer	7.47e-06	4.38e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.38e-06	4.33e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TYMS—prostate cancer	7.16e-06	4.2e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TYMS—prostate cancer	7.1e-06	4.16e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—prostate cancer	7.07e-06	4.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CAV1—prostate cancer	7.02e-06	4.12e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—prostate cancer	7.01e-06	4.11e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LPL—prostate cancer	6.94e-06	4.07e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LPL—prostate cancer	6.88e-06	4.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.71e-06	3.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1A1—prostate cancer	6.71e-06	3.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ERCC2—prostate cancer	6.65e-06	3.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1A1—prostate cancer	6.65e-06	3.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ERCC2—prostate cancer	6.59e-06	3.87e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CG—prostate cancer	6.4e-06	3.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTHFR—prostate cancer	6.25e-06	3.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTHFR—prostate cancer	6.2e-06	3.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARA—prostate cancer	6.13e-06	3.6e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARA—prostate cancer	6.08e-06	3.56e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—INS—prostate cancer	6.06e-06	3.55e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CREBBP—prostate cancer	5.93e-06	3.48e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CAV1—prostate cancer	5.77e-06	3.38e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CAV1—prostate cancer	5.72e-06	3.35e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CD—prostate cancer	5.63e-06	3.3e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.46e-06	3.2e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NOS3—prostate cancer	5.31e-06	3.11e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CG—prostate cancer	5.25e-06	3.08e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CG—prostate cancer	5.21e-06	3.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—INS—prostate cancer	4.97e-06	2.92e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—INS—prostate cancer	4.93e-06	2.89e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CB—prostate cancer	4.9e-06	2.87e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CREBBP—prostate cancer	4.87e-06	2.86e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—prostate cancer	4.86e-06	2.85e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CREBBP—prostate cancer	4.83e-06	2.83e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CD—prostate cancer	4.62e-06	2.71e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CD—prostate cancer	4.58e-06	2.68e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NOS3—prostate cancer	4.36e-06	2.56e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NOS3—prostate cancer	4.32e-06	2.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTEN—prostate cancer	4.24e-06	2.48e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—EP300—prostate cancer	4.04e-06	2.37e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CB—prostate cancer	4.03e-06	2.36e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.99e-06	2.34e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—prostate cancer	3.99e-06	2.34e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—prostate cancer	3.95e-06	2.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTEN—prostate cancer	3.48e-06	2.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTEN—prostate cancer	3.45e-06	2.02e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—EP300—prostate cancer	3.32e-06	1.94e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—EP300—prostate cancer	3.29e-06	1.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CA—prostate cancer	2.99e-06	1.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.45e-06	1.44e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—prostate cancer	2.44e-06	1.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.43e-06	1.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—prostate cancer	2e-06	1.18e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—prostate cancer	1.99e-06	1.17e-05	CbGpPWpGaD
